Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma.

Details

Language :

English

ISSN :

0732183X

Volume :

30

Issue :

16

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

76131316

Full Text :

https://doi.org/10.1200/JCO.2011.37.7069